Wnt signaling in cancer.
Open accessThe DOI matches its Crossref record; 90 of the 94 references it cites were found in a registry or an index.
Abstract
Aberrant regulation of the Wnt signaling pathway is a prevalent theme in cancer biology. From the earliest observation that Wnt overexpression could lead to malignant transformation of mouse mammary tissue to the most recent genetic discoveries gleaned from tumor genome sequencing, the Wnt pathway continues to evolve as a central mechanism in cancer biology. This article summarizes the evidence supporting a role for Wnt signaling in human cancer. This includes a review of the genetic mutations affecting Wnt pathway components, as well as some of epigenetic mechanisms that alter expression of genes relevant to Wnt. I also highlight some research on the cooperativity of Wnt with other signaling pathways in cancer. Finally, some emphasis is placed on laboratory research that provides a proof of concept for the therapeutic inhibition of Wnt signaling in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, APC, as a gene that upregulates WNT signaling, is negatively correlated with the frequency of T cell infiltration [196,197,198].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [197]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,429 · cited 1×
“Expression of the Wnt receptor FZD7 is characteristic of these types of breast cancer (Sorlie et al. 2003).”
BackgroundWnt signalling in stem cells and cancer
Reya, T., & Clevers, H. (2005) · Nature · doi:10.1038/nature03319 · Cited by 3,666 · cited 1×
“The impact ofb-catenin knockdown in cancers without identifiable genetic lesions in Wnt signaling could relate to the purported role of Wnt in the establishment and maintenance of so-called cancer stem cells (CSCs) (Reya and Clevers 2005; Malanchi and Huelsken 2009).”
Backgroundβ-Catenin regulates expression of cyclin D1 in colon carcinoma cells
Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601 · cited 1×
“Consequently, inhibition of target gene activation in colorectal cancer cells expressing the dominant negative TCF4 resulted in their growth arrest (Tetsu and McCormick 1999; van de Wetering et al. 2002).”
BackgroundThe Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,169 · cited 1×
“Paradoxically, mutations in TCF4, identified through genomic sequencing efforts of colorectal cancers, appear to be inactivating by compromising its ability to repress cell growth (Sjoblom et al. 2006; Tang et al. 2008).”
BackgroundThe M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820 · cited 1×
“PKM2 has received considerable attention lately, although mainly because of a renewed interest in the role of metabolism and aerobic glycolysis in cancer (Christofk et al. 2008).”
BackgroundThe β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells
van de Wetering, M., Sancho, E., Verweij, C., de Lau, W., Oving, I., Hurlstone, A., van der Horn, K., Batlle, E., Coudreuse, D., Haramis, A.-P., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)01014-0 · Cited by 2,030
Wnt signalling and its impact on development and cancer
Klaus, A., & Birchmeier, W. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2389 · Cited by 1,595 · cited 1×
“Ultimately, the TCF transcription factors that associated with b-catenin completed the understanding of a basic signaling pathway that could account for the potent tumori- genic effects of Wnt (reviewed by Klaus and Birchmeier 2008).”
Backgroundvan Es, J. H., van Gijn, M. E., Riccio, O., van den Born, M., Vooijs, M., Begthel, H., Cozijnsen, M., Robine, S., Winton, D. J., Radtke, F., et al. (2005) · Nature · doi:10.1038/nature03659 · Cited by 1,543 · cited 1×
“The impact of Notch in the intestine was consistent with previous work showing that its activation or inhibition increased or decreased the population of proliferating/progenitor cells, respectively, at the expense of the differentiated population (Fre et al. 2005; van Es et al. 2005).”
ResultMorin, R. D., Johnson, N. A., Severson, T. M., Mungall, A. J., An, J., Goya, R., Paul, J. E., Boyle, M., Woolcock, B. W., Kuchenbauer, F., et al. (2010) · Nature Genetics · doi:10.1038/ng.518 · Cited by 1,521
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
Jamieson, C. H. M., Ailles, L. E., Dylla, S. J., Muijtjens, M., Jones, C., Zehnder, J. L., Gotlib, J., Li, K., Manz, M. G., Keating, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040258 · Cited by 1,485 · cited 1×
“Granulocyticmacrophage progenitors isolated from CML patients show attributes of excessive Wnt signaling relative to normal progenitors and the introduction of the Wnt pathway inhibitor Axin decreased their capacity for proliferation and self-renewal (Jamieson et al. 2004).”
Background
Cited by
Items 301–400 of 859
Law, B. M. H., Waye, M. M. Y., So, W. K. W., & Chair, S. Y. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071352 · Cited by 46
“β-catenin is a protein that acts as a mediator of the effect of Wnt signalling, a signalling pathway known to contribute to cell proliferation and whose aberrant activation is implicated in cancer [64].”
BackgroundConnexin 43 is an independent predictor of patient outcome in breast cancer patients
Chasampalioti, M., Green, A. R., Ellis, I. O., Rakha, E. A., Jackson, A. M., Spendlove, I., & Ramage, J. M. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-5063-9 · Cited by 38
Liu, Y., Chang, Y., Lu, S., & Xiang, Y. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27825 · Cited by 38
“CCAT‐1 induces cervical cancer cell proliferation and inhibits cell apoptosis via Wnt signaling (Zhang & Gao, 2017).”
BackgroundJiang, H., Li, Y., Li, J., Zhang, X., Niu, G., Chen, S., & Yao, S. (2019) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835919874649 · Cited by 38
RetractedHereditary diffuse gastric cancer (HDGC). An overview
Taja‐Chayeb, L., Vidal-Millán, S., Trejo‐Becerril, C., Pérez‐Cárdenas, E., Chávez-Blanco, A. D., Domínguez-Gómez, G., González‐Fierro, A., Romo‐Pérez, A., & Dueñas‐González, A. (2021) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2021.101820 · Cited by 41
The effect of Wnt/β-catenin signaling on PD-1/PDL-1 axis in HPV-related cervical cancer
Aghbash, P. S., Hemmat, N., Baradaran, B., Mokhtarzadeh, A., Poortahmasebi, V., Oskouee, M. A., & Baghi, H. B. (2022) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2022.026776 · Cited by 41
“Furthermore, other factors that participate in tumorgenesis, including c-MYC, metalloproteinase 7 (MMP-7), and the vascular endothelial growth factor (VEGF), are stimulated by the β-catenin/TCF-LEF complex [35].”
BackgroundCroy, H. E., Fuller, C. N., Giannotti, J., Robinson, P., Foley, A. V. A., Yamulla, R. J., Cosgriff, S., Greaves, B. D., von Kleeck, R. A., An, H. H., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.705442 · Cited by 37
“Truncating mutations in the tumor suppressor adenomatous polyposis coli (APC) are the initiating mutational event in more than 80% of all colon cancer cases, and these mutations hyperactivate cat signaling (4).”
BackgroundKling, J. C., & Blumenthal, A. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.1mr0616-272r · Cited by 36
The canonical Wnt/β-catenin signaling pathway stimulates herpes simplex virus 1 productive infection
Zhu, L., & Jones, C. (2018) · Virus Research · doi:10.1016/j.virusres.2018.07.020 · Cited by 40
Glucocorticoids Influencing Wnt/β-Catenin Pathway; Multiple Sites, Heterogeneous Effects
Mészáros, K. V., & Patócs, A. (2020) · Molecules · doi:10.3390/molecules25071489 · Cited by 43
Activation of the Wnt/β-catenin signaling cascade after traumatic nerve injury
Kurimoto, S., Jung, J., Tapadia, M. D., Lengfeld, J. E., Agalliu, D., Waterman, M. L., Mozaffar, T., & Gupta, R. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.02.049 · Cited by 41
“Recent advancements and studies have shown that the Wnt/β-catenin signaling cascade plays a crucial role in tumor biology (Polakis, 2012).”
BackgroundDeconvolution of single-cell multi-omics layers reveals regulatory heterogeneity
Liu, L., Liu, C., Quintero, A., Wu, L., Yuan, Y., Wang, M., Cheng, M., Leng, L., Xu, L., Dong, G., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/316208 · Cited by 37
Shin, H., Choi, H., So, D., Kim, Y., Cho, K., Chung, H., Lee, K., Chun, Y., Cho, C., Kang, G. H., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.04.047 · Cited by 36
Perotti, D., Hohenstein, P., Bongarzone, I., Maschietto, M. C., Weeks, M., Radice, P., & Pritchard‐Jones, K. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0335 · Cited by 36
“reported in several human cancers (21, 22).”
InfluentialThe roles of ARHGAP10 in the proliferation, migration and invasion of lung cancer cells
Teng, J., Yang, Z., Zhu, Y., Ni, D., Zhu, Z., & Li, X. (2017) · Oncology Letters · doi:10.3892/ol.2017.6729 · Cited by 36
“The Wnt pathway plays diverse roles in the progression, metastasis and initiation of various types of cancer (25). c-Myc, a target gene of Wnt/ β -catenin signaling suppresses the accumulation of p21, a cyclin-dependent kinase (CDK) inhibitor (26).”
Kim, S.-J., Lee, S., & Kim, K. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-0950-2_12 · Cited by 39
Targeting Wnt Signaling via Notch in Intestinal Carcinogenesis
Kaemmerer, E., Jeon, M. K., Berndt, A., Liedtke, C., & Gaßler, N. (2019) · Cancers · doi:10.3390/cancers11040555 · Cited by 40
Oncoprotein-specific molecular interaction maps (SigMaps) for cancer network analyses
Broyde, J., Simpson, D. R., Murray, D., Paull, E., Chu, B., Tagore, S., Jones, S. J., Griffin, A. T., Giorgi, F. M., Lachmann, A., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0652-7 · Cited by 33
Haiaty, S., Rashidi, M., Akbarzadeh, M., Bazmani, A., Mostafazadeh, M., Nikanfar, S., Zibaei, Z., Rahbarghazi, R., & Nouri, M. (2021) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-021-03246-w · Cited by 36
“The effectors such as PI3K and Wnt3a participate in different activities of cancer cells [31, 32].”
Backgroundβ-Catenin Activation in Hepatocellular Cancer: Implications in Biology and Therapy
Krutsenko, Y., Singhi, A. D., & Monga, S. P. (2021) · Cancers · doi:10.3390/cancers13081830 · Cited by 40
“The protein later termed Wnt1 was first identified almost 40 years ago in the context of its proto-oncogenic nature [1,2].”
BackgroundPluripotent Stem Cells: Cancer Study, Therapy, and Vaccination
Barati, M., Akhondi, M., Mousavi, N. S., Haghparast, N., Ghodsi, A., Baharvand, H., Ebrahimi, M., & Hassani, S. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10199-7 · Cited by 39
Chłopek, M., Lasota, J. P., Thompson, L. D. �., Szczepaniak, M., Kuźniacka, A., Hińcza, K., Kubicka, K., Kaczorowski, M., Newford, M., Liu, Y., et al. (2022) · Modern Pathology · doi:10.1038/s41379-022-01122-7 · Cited by 47
Sammak, S., & Zinzalla, G. (2015) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2015.06.004 · Cited by 43
A Comparative Perspective on Wnt/β-Catenin Signalling in Cell Fate Determination
Garcin, C. L., & Habib, S. J. (2017) · Results and problems in cell differentiation · doi:10.1007/978-3-319-53150-2_15 · Cited by 43
Cui, J., Xi, H., Cai, A., Bian, S., Wei, B., & Chen, L. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1759 · Cited by 38
“the aberrant activation of the Wnt/β-catenin pathway in human cancers (19-21).”
Distinct DNA Binding Sites Contribute to the TCF Transcriptional Switch in C. elegans and Drosophila
Bhambhani, C., Ravindranath, A. J., Mentink, R. A., Chang, M. V., Betist, M. C., Yang, Y., Koushika, S. P., Korswagen, H. C., & Cadigan, K. M. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004133 · Cited by 37
Deng, F., Zhou, K., Cui, W., Liu, D., & Ma, Y. (2015) · PubMed · Cited by 36
The β-catenin signaling pathway stimulates bovine herpesvirus 1 productive infection
Zhu, L., Thunuguntla, P., Liu, Y., Hancock, M., & Jones, C. (2016) · Virology · doi:10.1016/j.virol.2016.10.014 · Cited by 38
“The Wnt/β-catenin signaling pathway is required for embryogenesis and adult homeostasis, reviewed in (13, 16).”
BackgroundPoorebrahim, M., Sadeghi, S., Rahimi, H., Karimipoor, M., Azadmanesh, K., Mazlomi, M. A., & Teimoori‐Toolabi, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172217 · Cited by 35
“This signaling pathway has an important role in tumorigenesis of several human cancers and is most often deregulated in colorectal cancer (CRC) facilitating malignant development of polyps in the intestinal epithelium [2, 3].”
BackgroundLee, H.-K., Lee, E., Seo, J., Jeong, M., Lee, S.-H., Kim, S., Jho, E., Choi, C. H., Chung, J., & Song, J. (2018) · Oncogene · doi:10.1038/s41388-018-0267-3 · Cited by 38
Lutze, G., Haarmann, A., Toukam, J. A. D., Buttler, K., Wilting, J., & Becker, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-41299-7 · Cited by 32
Jiang, X., Li, S., Qiu, X., Cong, J., Zhou, J., & Miu, W. (2019) · Medical Science Monitor · doi:10.12659/msm.918364 · Cited by 39
“Recent studies have shown an association between CDX2 and CRC [8].”
BackgroundInfluentialFAT10: Function and Relationship with Cancer
Xiang, S., Shao, X., Cao, J., Yang, B., He, Q., & Ying, M. (2019) · Current Molecular Pharmacology · doi:10.2174/1874467212666191113130312 · Cited by 35
Wnt and Vitamin D at the Crossroads in Solid Cancer
González‐Sancho, J. M., Larriba, M. J., & Múñoz, A. (2020) · Cancers · doi:10.3390/cancers12113434 · Cited by 35
“In fact, aberrant activation of the Wnt/β-catenin pathway is the most common event in human colorectal cancer (CRC) [14,15] in which massive sequencing has estimated that over 94% of primary colon tumors carry mutations in one or more genes involved in this pathway [16].”
BackgroundTargets of Wnt/ß-Catenin Transcription in Penile Carcinoma
Arya, M., Thrasivoulou, C., Henrique, R., Millar, M., Hamblin, R., Davda, R., Aare, K., Masters, J. R., Thomson, C., Muneer, A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124395 · Cited by 39
“Targets of ß-catenin transcription are also over-expressed in many squamous cell carcinomas [24–26] (see [14] for a review).”
BackgroundThe role of aryl hydrocarbon receptor in bone remodeling
Yu, H., Jiang, L., Wan, B., Zhang, W., Yao, L., Che, T., Gan, C., Su, N., He, J., Huang, J., et al. (2017) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2017.12.005 · Cited by 34
Pan, F., Shen, F., Yang, L., Zhang, L., Guo, W., & Tian, J. (2018) · Oncology Letters · doi:10.3892/ol.2018.8790 · Cited by 37
Wnt2 contributes to the progression of gastric cancer by promoting cell migration and invasion
Zhang, Z., Wang, J., & Dong, X. (2018) · Oncology Letters · doi:10.3892/ol.2018.9050 · Cited by 34
“Previous research has highlighted the importance of the Wnt signaling pathway, which is involved in the regulation of cell proliferation, differentiation, apoptosis and migration (4-6).”
BackgroundAdvances in the proteomic discovery of novel therapeutic targets in cancer
Guo, S., Zou, J., & Wang, G. (2013) · Drug Design Development and Therapy · doi:10.2147/dddt.s52216 · Cited by 42
Li, S., Shi, C.-J., Fu, W.-M., & Zhang, J. (2022) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgac067 · Cited by 33
Wnt Signaling in the Development of Bone Metastasis
Ben-Ghedalia-Peled, N., & Vago, R. (2022) · Cells · doi:10.3390/cells11233934 · Cited by 38
Preventive Role of Resveratrol Against Inflammatory Cytokines and Related Diseases
Rafe, T., Shawon, P. A., Salem, L., Chowdhury, N. I., Kabir, F., Zahur, S. M. B., Akhter, R., Noor, H. B., Mohib, M. M., & Sagor, M. A. T. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190410153307 · Cited by 37
Generation of the tumor-suppressive secretome from tumor cells
Liu, S., Sun, X., Li, K., Zha, R., Feng, Y., Sano, T., Dong, C., Liu, Y., Aryal, U. K., Sudo, A., et al. (2021) · Theranostics · doi:10.7150/thno.61006 · Cited by 34
“The derailed activation of Wnt signaling is reported to promote the progression of tumors and many studies have been directed to inhibit Wnt activation for cancer treatments [6, 7].”
BackgroundWnt Secretion and Gradient Formation
Solis, G. P., Lüchtenborg, A., & Katanaev, V. L. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14035130 · Cited by 38
“Therefore, it is not surprising that its improper activation causes a wide range of human diseases, most notably cancer [2–4].”
BackgroundSOST Inhibits Prostate Cancer Invasion
Hudson, B. D., Hum, N. R., Thomas, C. B., Kohlgruber, A. C., Sebastian, A., Collette, N. M., Coleman, M. A., Christiansen, B., & Loots, G. G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142058 · Cited by 36
“While loss of function mutations in Wnt signaling pathway genes are common to several cancers [19], the activation of Wnt signaling through the accumulation of nuclear β-catenin has also been documented for PC [5, 20].”
BackgroundPlatforms for high-throughput screening of Wnt/Frizzled antagonists
Koval, A., & Katanaev, V. L. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.07.007 · Cited by 35
E-cadherin gene re-expression in chronic lymphocytic leukemia cells by HDAC inhibitors
Jordaan, G., Liao, W., & Sharma, S. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-88 · Cited by 32
“The wnt-β-catenin pathway is a pro-growth and survival pathway that is active in multiple tumor types including chronic lymphocytic leukemia (CLL) [1-3].”
BackgroundRoy, S., Liu, F., & Arav‐Boger, R. (2015) · Viruses · doi:10.3390/v8010008 · Cited by 34
Chang, T., Wei, K., Lu, C., Chen, Y.-H., Cheng, Y.-T., Tung, S., Wu, C., & Chiang, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020460 · Cited by 32
Methyllysine binding domains: Structural insight and small molecule probe development
Teske, K. A., & Hadden, M. K. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.04.047 · Cited by 32
“As a key effector involved in Wnt signaling, b-catenin binds to TCF/LEF transcription factors to activate cell differentiation [124].”
BackgroundMojsin, M. M., Marjanović, J., Schwirtlich, M., Topalović, V., & Stevanović, M. J. (2014) · Food & Function · doi:10.1039/c4fo00484a · Cited by 32
Mortensen, M. M., Høyer, S., Orntoft, T. F., Sørensen, K. D., Dyrskjøt, L., & Borre, M. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-859 · Cited by 31
“Regarding studies of aggressive PC, tumor heterogeneity has often been overlooked.”
BackgroundYamulla, R. J., Kane, E. G., Moody, A. E., Politi, K. A., Lock, N. E., Foley, A. V. A., & Roberts, D. M. (2014) · Genetics · doi:10.1534/genetics.114.166496 · Cited by 32
Zhu, Y., Zhang, B., Gong, A., Fu, H., Zhang, X., Shi, H., Sun, Y., Wu, L., Pan, Z., Mao, F., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7684 · Cited by 32
Zins, K., Schäfer, R., Paulus, P., Dobler, S., Fakhari, N., Sioud, M., Aharinejad, S., & Abraham, D. (2016) · Oncotarget · doi:10.18632/oncotarget.10070 · Cited by 36
“Aberrant regulation of the Wnt signaling pathway is a prevalent theme in cancer biology [6].”
BackgroundOron, O., & Elliott, E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040828 · Cited by 33
Javan, B., Atyabi, F., & Shahbazi, M. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.04.011 · Cited by 31
Ding, J., Shi, F., Xie, G., & Zhu, Y. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06215-4 · Cited by 36
Beta-Catenin Versus the Other Armadillo Catenins
Miller, R. K., Hong, J. Y., Muñoz, W. A., & McCrea, P. D. (2013) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394311-8.00017-0 · Cited by 35
“Groucho and CtBP) [38] are shed in favor of coactivators/chromatin remodelers (e.”
Dentin Dysplasia in Notum Knockout Mice
Vogel, P., Read, R. W., Hansen, G. M., Powell, D. R., Kantaputra, P. N., Zambrowicz, B., & Brommage, R. (2016) · Veterinary Pathology · doi:10.1177/0300985815626778 · Cited by 31
Zhang, M., Wang, D., Zhu, T., & Yin, R. (2017) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504016x14719078133447 · Cited by 35
Deshmukh, A. P., Arfuso, F., Newsholme, P., & Dharmarajan, A. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.01.016 · Cited by 31
Keratin 17 upregulation promotes cell metastasis and angiogenesis in colon adenocarcinoma
Ji, R., Ji, Y.-F., Ma, L., Ge, S., Chen, J., Wu, S., Huang, T., Sheng, Y., Wang, L., Yi, N., et al. (2021) · Bioengineered · doi:10.1080/21655979.2021.2010393 · Cited by 27
“Previous reports show that abnormal regulation of the WNT signaling pathway is crucial in cancer biology [26] and β-catenin is related to poor cancer prognosis; nuclear accumulation of β-catenin can promote the proliferation and senescence of cancer cells [27].”
Brauburger, K., Akyildiz, S., Ruppert, J. G., Graeb, M., Bernkopf, D. B., Hadjihannas, M. V., & Behrens, J. (2013) · FEBS Journal · doi:10.1111/febs.12624 · Cited by 34
Wnt Lipidation and Modifiers in Intestinal Carcinogenesis and Cancer
Kaemmerer, E., & Gaßler, N. (2016) · Cancers · doi:10.3390/cancers8070069 · Cited by 30
Lin, J., Tan, X., Qiu, L., Huang, L., Zhou, Y., Pan, Z., Liu, R., Chen, S., Geng, R., Wu, J., et al. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.07.009 · Cited by 32
“The Wnt/b-catenin canonical signaling pathway, which was previously regarded as a key pathway involved in determining cell fate,(35) has been found to be deregulated in various cancers.(36) The Wnt signaling pathway has been reported be altered in 93% of colorectal tumors.”
BackgroundWnt lipidation: Roles in trafficking, modulation, and function
Hosseini, V., Dani, C., Geranmayeh, M. H., Mohammadzadeh, F., Ahmad, S. N. S., & Darabi, M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27570 · Cited by 32
“This process may be executed by directly appending Wnts to extracellular particles such as afamin, secreted wingless‐interacting molecule (Swim), exosomes, and lipoproteins (Mulligan et al., 2012, Neumann et al., 2009, Port & Basler, 2010).”
BackgroundLaFramboise, W. A., Pai, R. K., Petrosko, P., Belsky, M. A., Dhir, A., Howard, P. G., Becich, M. J., Holtzman, M. P., Ahrendt, S. A., Pingpank, J. F., et al. (2019) · Modern Pathology · doi:10.1038/s41379-019-0256-2 · Cited by 31
Casein Kinase 1α as a Regulator of Wnt-Driven Cancer
Shen, C., Nayak, A., Meléndez, R. A., Wynn, D. T., Jackson, J., Lee, E. N., Ahmed, Y. F., & Robbins, D. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165940 · Cited by 33
Zhang, W., Sviripa, V. M., Xie, Y., Yu, T., Haney, M. G., Blackburn, J. S., Adeniran, C. A., Zhan, C., Watt, D. S., & Liu, C. (2020) · iScience · doi:10.1016/j.isci.2020.101795 · Cited by 33
“Small-molecule inhibitors that target these epigenetic mechanisms are attractive agents for regulating transcription and developing new antineoplastic drugs, particularly in the case of CRC where Wnt signaling is important (Patnaik and Anupriya, 2019; Polakis, 2012).”
BackgroundMicroRNA Interrelated Epithelial Mesenchymal Transition (EMT) in Glioblastoma
Damane, B. P., Hull, R., Reis, R. M., Agbor, C. A., Ambele, M. A., Mulaudzi, T. V., & Dlamini, Z. (2022) · Genes · doi:10.3390/genes13020244 · Cited by 34
“The pathway has a dual role in cancer, being composed of a myriad of oncogenes and tumor suppressors, with genes coding for the components of the anaphase-promoting complex (APC) being the most frequently mutated [38].”
BackgroundZHOU, L., Park, J. K., Jang, K. Y., Park, H. S., Wagle, S., Yang, K. H., Lee, K., Park, B., & Kim, J. R. (2013) · Oncology Reports · doi:10.3892/or.2013.2569 · Cited by 30
Yuan, G., Zhang, B., Yang, S., Jin, L., Datta, A., Bae, S., Chen, X., & Datta, P. K. (2016) · Oncotarget · doi:10.18632/oncotarget.7532 · Cited by 31
Guo, H., Lv, X., Li, Y., & Li, M. (2023) · Briefings in Functional Genomics · doi:10.1093/bfgp/elad013 · Cited by 35
Inhibition of Wnt Signaling by Silymarin in Human Colorectal Cancer Cells
Eo, H. J., Park, G. H., & Jeong, J. B. (2016) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2015.154 · Cited by 31
“The protein level of β-catenin has been known to be regulated by phosphorylation-dependent and ubiquitin-mediated degradation (Polakis, 2012). β-catenin is phosphorylated by GSK3β at Thr41, Ser37 (Liu et al., 2002) and Ser33, and subsequently is degraded via the proteasome pathway (Aberle et al.,…”
BackgroundBiological significance of genome‐wide DNA methylation profiles in keloids
Jones, L. R., Greene, J. B., Chen, K. M., Divine, G., Chitale, D. A., Shah, V. V., Datta, I., & Worsham, M. J. (2016) · The Laryngoscope · doi:10.1002/lary.26063 · Cited by 32
“The epigenetic alterations of genes in the Wnt signaling pathway and its interaction with other pathways have been implicated in tumor progression via both proto-oncogene and tumor suppressor activity.(23) Other colorectal cancer metastasis signaling pathway alterations include TGF-b signaling, which is important in w…”
BackgroundHamdoun, S., Fleischer, E., Klinger, A., & Efferth, T. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.10.008 · Cited by 30
Norum, J. H., Skarpen, E., Brech, A., Kuiper, R., Waaler, J., Krauss, S. J. K., & Sørlie, T. (2018) · Biological Research · doi:10.1186/s40659-017-0151-6 · Cited by 34
“Background Regulation of the wingless-type MMTV integration site family member (WNT)/β-catenin pathway, is attenuated in several cancers [1].”
Pathway perturbations in signaling networks: Linking genotype to phenotype
Li, Y., McGrail, D. J., Latysheva, N. S., Yi, S. S., Babu, M. M., & Sahni, N. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.05.001 · Cited by 30
Toll‐like receptor 4 regulates spontaneous intestinal tumorigenesis by up‐regulating IL‐6 and GM‐CSF
Shi, Y., Zhao, Q., Liu, X., Dong, S., Jifu, E., Xu, L., Liu, C., & Wang, H. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14742 · Cited by 29
Nuclear receptor CAR-mediated liver cancer and its species differences
Shizu, R., & Yoshinari, K. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1746268 · Cited by 29
MIR4435-2HG: A newly proposed lncRNA in human cancer
Zhang, M., Yu, X., Zhang, Q., Sun, Z., He, Y., & Guo, W. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112971 · Cited by 29
Wnt4 is overexpressed in human pituitary adenomas and is associated with tumor invasion
Li, W., Zhang, Y., Zhang, M., Huang, G., & Zhang, Q. (2013) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2013.04.034 · Cited by 28
“Wnt4 has been recently shown to regulate multiple developmental processes including the expansion of several cell types of the pituitary gland [5,8].”
BackgroundKim, W. K., Bach, D., Ryu, H. W., Oh, J., Park, H. J., Hong, J., Song, H., Eum, S. M., Bách, T. T., & Lee, S. K. (2017) · Phytomedicine · doi:10.1016/j.phymed.2017.08.008 · Cited by 30
Prada, E. T. A., & Auernhammer, C. J. (2017) · Endocrine Connections · doi:10.1530/ec-17-0286 · Cited by 33
Therapeutic targets associated to E-cadherin dysfunction in gastric cancer
Carneiro, P., Figueiredo, J., Bordeira–Carriço, R., Fernandes, M. S., Carvalho, J., Oliveíra, C., & Seruca, R. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.827174 · Cited by 33
“Membrane-unbound b-ctn interacts with T-cell (TCF) and lymphoid enhancing (LEF) transcription factors activating the transcription of Wnttarget genes including myc, LEF, cyclinD1, and MMP family members, among others [104,105].”
BackgroundHistology and Molecular Aspects of Central Neurocytoma
Bonney, P. A., Boettcher, L. B., Krysiak, R. S., Fung, K.-M. A., & Sughrue, M. E. (2014) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2014.09.001 · Cited by 28
Paulucci, D. J., Sfakianos, J. P., Skanderup, A. J., Kan, K. M., Tsao, C., Galsky, M. D., Hakimi, A. A., & Badani, K. K. (2016) · Oncotarget · doi:10.18632/oncotarget.14122 · Cited by 29
“Additionally, overexpression of CRYBB2 which is associated with the WNT signaling pathway involved in tumor progression, growth, differentiation and metastases [22, 23] may also contribute to worse survival observed in black patients with RCC.”
BackgroundHang, H., Liu, X., Wang, H.-T., Xu, N., Bian, J., Zhang, J., Xia, L., & Xia, Q. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.08.020 · Cited by 28
Mohammadi‐Yeganeh, S., Hosseini, V., & Paryan, M. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28465 · Cited by 28
“Dysregulation in Wnt signaling, the hallmark of TNBC, has been observed in these patients (Pires, IS, Souza, Rodrigues, & Mencalha, 2016; Polakis, 2012).”
BackgroundZheng, X., Lin, J., Wu, H., Mo, Z., Lian, Y., Wang, P., Hu, Z., Gao, Z., Peng, L., & Xie, C. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1433-3 · Cited by 28
RetractedSMAD4 is critical in suppression of BRAF-V600E serrated tumorigenesis
Tong, K., Kothari, O. A., Haro, K. S., Panda, A., Bandari, M., Carrick, J. N., Hur, J., Zhang, L., Chan, C. S., Xing, J., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01997-x · Cited by 31
Wong, E. W. P., Lee, W. M., & Cheng, C. Y. (2012) · The FASEB Journal · doi:10.1096/fj.12-212514 · Cited by 28
“Conversely, Wnt has been shown to be activated in different carcinomas, inducing their migration (22, 71), which can be mediated by FAK (72).”
BackgroundDistinct DNA Methylation Profiles in Ovarian Tumors: Opportunities for Novel Biomarkers
Losi, L., Fonda, S., Saponaro, S., Chelbi, S. T., Lancellotti, C., Gozzi, G., Alberti, L., Fabbiani, L., Botticelli, L., & Benhattar, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061559 · Cited by 29
“Wnt activation has been observed in several cancer types, including colorectal carcinoma, pancreatic adenocarcinoma, leukemia, melanoma, but also in ovarian carcinoma [48].”
BackgroundSmail, S. W., Bergsten, P., Taha, K. O., Yashooa, R. K., Hawezy, D. J., Abbas, M. A., & Shekha, M. S. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1695200 · Cited by 38
“They do so by trapping Wnt ligands or blocking receptor interaction (Polakis, 2012), as shown in Figure 4.”
Kang, J.-I., Yoo, E.-S., Hyun, J. W., Koh, Y., Lee, N. H., Ko, M.-H., Ko, C.-S., & Kang, H. (2016) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b16-00024 · Cited by 28
A silyl andrographolide analogue suppresses Wnt/β-catenin signaling pathway in colon cancer
Reabroi, S., Chairoungdua, A., Saeeng, R., Kasemsuk, T., Saengsawang, W., Zhu, W., & Piyachaturawat, P. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.119 · Cited by 29
Atkinson, B. N., Steadman, D., Zhao, Y., Sipthorp, J., Vecchia, L., Ruza, R. R., Jeganathan, F., Lines, G., Frew, S., Monaghan, A. E., et al. (2019) · MedChemComm · doi:10.1039/c9md00096h · Cited by 27
Pten loss in Lgr5+ hair follicle stem cells promotes SCC development
Chen, H., Wang, X., Chen, Y., Han, J., Kong, D., Zhu, M., Fu, X., & Wu, Y. (2019) · Theranostics · doi:10.7150/thno.35467 · Cited by 29
“Wnt/β-catenin exhibits complicated effect on both the development of stem cells and cancers [35-38].”
β-catenin S45F mutation results in apoptotic resistance
Braggio, D., Zewdu, A., Londhe, P., Yu, P., Lopez, G., Batte, K., Koller, D., de Faria, F. C. C., Casadei, L., Strohecker, A. M., et al. (2020) · Oncogene · doi:10.1038/s41388-020-1382-5 · Cited by 27
Metadata
- Authors
- Polakis, P.
- Affiliations
- Genentech (US)
- Corresponding author
- Polakis, P.
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2012-03-20
- Volume
- 4
- Issue
- 5
- Pages
- a008052-a008052
- ISSN
- 1943-0264 (ISSN-L)
- PMC
- PMC3331705
- OpenAlex
- W2149598894
- Cited by
- 847
- References
- 94
- Citations by year
- 2026: 13 · 2025: 21 · 2024: 41 · 2023: 36 · 2022: 56 · 2021: 85 · 2020: 76 · 2019: 77 · 2018: 76 · 2017: 95 · 2016: 89 · 2015: 64 · 2014: 54 · 2013: 51 · 2012: 13
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cold Spring Harbor Perspectives in Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- Wnt signaling, cancer, epigenetic regulation, Wnt inhibitors, malignant transformation, tumor genome sequencing
- MeSH terms
- Humans, Models, Biological, Mutation, Neoplasms, Oncogene Proteins, Tumor Suppressor Proteins, Epigenesis, Genetic, Wnt Signaling Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.